Related references
Note: Only part of the references are listed.Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies
Jan-Peer Elshoff et al.
CLINICAL THERAPEUTICS (2012)
ROTIGOTINE TRANSDERMAL PATCH FOR THE TREATMENT OF PARKINSON'S DISEASE AND RESTLESS LEGS SYNDROME
B. Boroojerdi et al.
DRUGS OF TODAY (2010)
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease
Dieter Scheller et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
Willi Cawello et al.
DRUG METABOLISM AND DISPOSITION (2009)
Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine
M. Malik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
Werner H. Poewe et al.
LANCET NEUROLOGY (2007)
Advanced Parkinson disease treated with rotigotine transdermal system - PREFER Study
Peter A. LeWitt et al.
NEUROLOGY (2007)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Pergolide versus levodopa monotherapy in early Parkinson's disease patients:: The PELMOPET study
WH Oertel et al.
MOVEMENT DISORDERS (2006)
Potential of transdermal drug delivery in Parkinson's disease
RF Pfeiffer
DRUGS & AGING (2002)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
R Holloway et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
JG Nutt et al.
TRENDS IN NEUROSCIENCES (2000)
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
O Rascol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
